Brain Energy Deficit As a Source of Oxidative Stress in Migraine: A Molecular Basis for Migraine Susceptibility
Overview
Authors
Affiliations
People with migraine are prone to a brain energy deficit between attacks, through increased energy demand (hyperexcitable brain) or decreased supply (mitochondrial impairment). However, it is uncertain how this precipitates an acute attack. Here, the central role of oxidative stress is adduced. Specifically, neurons' antioxidant defenses rest ultimately on internally generated NADPH (reduced nicotinamide adenine dinucleotide phosphate), whose levels are tightly coupled to energy production. Mitochondrial NADPH is produced primarily by enzymes involved in energy generation, including isocitrate dehydrogenase of the Krebs (tricarboxylic acid) cycle; and an enzyme, nicotinamide nucleotide transhydrogenase (NNT), that depends on the Krebs cycle and oxidative phosphorylation to function, and that works in reverse, consuming antioxidants, when energy generation fails. In migraine aura, cortical spreading depression (CSD) causes an initial severe drop in level of NADH (reduced nicotinamide adenine dinucleotide), causing NNT to impair antioxidant defense. This is followed by functional hypoxia and a rebound in NADH, in which the electron transport chain overproduces oxidants. In migraine without aura, a similar biphasic fluctuation in NADH very likely generates oxidants in cortical regions farthest from capillaries and penetrating arterioles. Thus, the perturbations in brain energy demand and/or production seen in migraine are likely sufficient to cause oxidative stress, triggering an attack through oxidant-sensing nociceptive ion channels. Implications are discussed for the development of new classes of migraine preventives, for the current use of C57BL/6J mice (which lack NNT) in preclinical studies of migraine, for how a microembolism initiates CSD, and for how CSD can trigger a migraine.
Golpour-Hamedani S, Bagherniya M, Khorvash F, Feizi A, Sharma M, Askari G Nutr J. 2025; 24(1):40.
PMID: 40082970 PMC: 11905556. DOI: 10.1186/s12937-025-01107-7.
Abo-Elghiet F, Elosaily H, Hussein D, El-Shiekh R, Aaqoulah A, Yousef E Pharmaceuticals (Basel). 2025; 18(2).
PMID: 40005953 PMC: 11858087. DOI: 10.3390/ph18020139.
Sexual Dimorphism in Migraine. Focus on Mitochondria.
Fila M, Przyslo L, Derwich M, Pawlowska E, Blasiak J Curr Pain Headache Rep. 2025; 29(1):11.
PMID: 39760955 DOI: 10.1007/s11916-024-01317-4.
Practical supplements for prevention and management of migraine attacks: a narrative review.
Hajhashemy Z, Golpour-Hamedani S, Eshaghian N, Sadeghi O, Khorvash F, Askari G Front Nutr. 2024; 11:1433390.
PMID: 39539367 PMC: 11557489. DOI: 10.3389/fnut.2024.1433390.
Luwen H, Ping C, Qing-Rong O, Lei X, Linlin L, Yu M Medicine (Baltimore). 2024; 103(45):e40458.
PMID: 39533580 PMC: 11557034. DOI: 10.1097/MD.0000000000040458.